ENACT HOLDINGS INC

Company Overview

Enact Holdings, Inc. (Financial Services — Insurance - Specialty) is a U.S. private mortgage insurer that issues primary residential mortgage guaranty insurance through Enact Mortgage Insurance Corporation (EMICO) and manages reinsurance capacity via Enact Re. The company wrote $51.0 billion of new insurance in 2024, reported net income of $688 million and adjusted operating income of $718 million, and maintains a $5.6 billion fixed‑maturity portfolio with PMIERs sufficiency near 167%. Its operating model emphasizes data‑driven underwriting, delegated channels (~70% of NIW), proprietary modeling and a diversified credit risk transfer (CRT) program to stabilize loss volatility. Business performance is cyclical and sensitive to mortgage origination mix, housing prices, delinquency trends and regulatory capital regimes.

Executive Compensation Practices

Compensation is likely tied to underwriting profitability and capital metrics—measures such as adjusted operating income, loss ratios/reserve adequacy, return on statutory surplus/RTC and maintenance of PMIERs sufficiency will materially drive annual bonuses and long‑term equity awards. Given the importance of investment income and tactical portfolio management in 2024–25, incentive plans may also include investment yield, realized‑gain/loss controls and metrics that reward prudent asset/liability management. As a regulated insurer, pay design will be influenced by statutory surplus constraints and dividend upstream rules (EMICO upstreams require regulatory consideration), so pay programs commonly emphasize deferred equity, multi‑year performance vesting and clawbacks tied to reserve adjustments or capital shortfalls. Retention of specialists (credit modeling, delegated underwriting, AI/ML teams) and alignment with CRT/reinsurance outcomes likely produce a mix of cash, long‑term equity and performance‑based awards.

Insider Trading Considerations

Insider trades at an insurer like Enact are most informative around quarterly reserve releases, delinquency trend disclosures, CRT or reinsurance placements, and capital actions (dividend announcements, buyback authorizations and note issuances), since these events materially affect statutory surplus and market perception. Regulatory constraints—state insurance department oversight of upstream dividends, PMIERs/RTC limits and potential supervisory reviews—can delay or limit distributions and therefore influence the timing and structure of insider sales (e.g., reliance on Rule 10b5‑1 plans). Because management commentary on small assumption changes can move reserves substantially, look for insider selling before or after reserve methodology updates or before quarters showing rising delinquencies as potential signals. Red flags include concentrated, large‑volume insider sales immediately prior to adverse reserve or delinquency disclosures; conversely, insider buying during weakness can signal confidence in capital sufficiency (e.g., PMIERs ~165–167%).